The Age of (Over)Discovery

Journal of the American College of Radiology

Volumn 7, Issue 4, 2010, Pages 246-247

  Warshauer, David M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; INCIDENTAL FINDING; NEOPLASM; RISK FACTOR; ULTRASOUND;

EID: 84928096537     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2009.11.001     Document Type: Article

References (11)

1. Sistrom C.L., Dreyer K.J., Dang P.P., et al. Recommendations for additional imaging in radiology reports: multifactorial analysis of 5.9 million examinations. Radiology 253 (2009) 453-461
2. Blaivas M., and Lyon M. Frequency of radiology self-referral in abdominal computed tomographic scans and the implied cost. Am J Emerg Med 25 (2007) 396-399
3. Office on Smoking and Health, National Center of Chronic Disease Prevention and Health Promotion. 2004 surgeon general's report-the health consequences of smoking (2004), US Department of Health and Human Resources, Washington, DC
4. National Cancer Institute. SEER cancer statistics review 1975-2006. http://www.seer.cancer.gov/csr/1975_2006/index.html Accessed December 19, 2009
5. Ros D. Nonpalpable thyroid nodules-managing an epidemic. J Clin Endocrinol Metab 87 (2002) 1938-1940
6. Zahl P., Maehlen J., and Welch H. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 168 (2008) 2311-2313
7. Bach P. Is our natural-history model of lung cancer wrong?. Lancet Oncol 9 (2008) 693-697
8. Esserman L., Shieh Y., and Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 302 (2009) 1685-1692
9. Cronan J. Thyroid nodules: is it time to turn off the US machines?. Radiology 247 (2008) 602-604
10. Verdun F., Bochud F., Gudinchet F., Aroua A., Schnyder P., and Meuli R. Quality initiatives: radiation risk: what you should know to tell your patient. Radiographics 28 (2008) 1807-1816
11. Howard K., Barratt A., Mann G., and Patel M. A model of prostate-specific antigen screening outcomes for low to high-risk men. Information to support informed choices. Arch Intern Med 169 (2009) 1603-1610